Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bionano Genomics Inc

Current price
1.47 USD -0.05 USD (-3.29%)
Last closed 1.67 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 64 474 896 USD
Yield for 12 month -30.66 %
21.11.2021 - 28.11.2021

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California. Address: 9540 Towne Centre Drive, San Diego, CA, United States, 92121


WallStreet Target Price

12.33 USD

P/E ratio

Dividend Yield

Current Year

+27 802 000 USD

Last Year

+17 981 000 USD

Current Quarter

+9 318 000 USD

Last Quarter

+8 662 000 USD

Current Year

+5 945 000 USD

Last Year

+3 874 000 USD

Current Quarter

+2 749 000 USD

Last Quarter

+2 308 000 USD

Key Figures BNGO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -133 269 000 USD
Operating Margin TTM -385.62 %
PE Ratio
Return On Assets TTM -36.13 %
PEG Ratio
Return On Equity TTM -113.43 %
Wall Street Target Price 12.33 USD
Revenue TTM 33 610 000 USD
Book Value 3.37 USD
Revenue Per Share TTM 1.06 USD
Dividend Share
Quarterly Revenue Growth YOY 29 %
Dividend Yield
Gross Profit TTM 5 945 000 USD
Earnings Share -7.17 USD
Diluted Eps TTM -7.17 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BNGO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BNGO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 07.08.2023
Dividend Date

Stock Valuation BNGO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.3283
Price Sales TTM 1.9183
Enterprise Value EBITDA -0.0521
Price Book MRQ 0.5418

Financials BNGO

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BNGO

For 52 weeks

1.19 USD 22.9 USD
50 Day MA 1.91 USD
Shares Short Prior Month 6 607 754
200 Day MA 6.02 USD
Short Ratio 6.06
Shares Short 7 079 690
Short Percent 18.31 %